Intervention 1: Intervention group: Patients hospitalized with COVID-19 disease who in addition to their standard treatment ( Hydroxychloroquine 400mg daily) will be received 1000mg/day Methylpredniso
Sponsors
Artesh University of Medical Sciences
Conditions
COVID-19 Disease.
COVID-19
Phase 3
Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome
RecruitingIRCT20200406046963N1
Start: 2020-03-30Target: 40Updated: 2020-05-18
Evaluation of the efficacy and safety of Adalimumab and methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome
RecruitingIRCT20200406046963N2
Start: 2021-06-18Target: 40Updated: 2021-08-30